News

One more death was reported from dengue in 24 hours till Sunday morning, raising the number of fatalities from the ...
The enrolment for phase III clinical trials of India's first dengue vaccine, DengiAll, is expected to be completed by October ...
Enrolment of about 10,500 participants in the phase III clinical trial of the indigenous one-shot Panacea Biotec developed ...
Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in ...
The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...
The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, ...
Explore more
Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.
In light of the recent spell of monsoon rains, Punjab Health Ministers Khawaja Salman Rafique and Khawaja Imran Nazir have stressed the need for immediate and emergency measures to prevent the spread ...
As summer ushers in peak mosquito season, health and vector control officials are bracing for the possibility of another year ...
Punjab's Health Minister Dr. Balbir Singh leads a surprise inspection as part of an anti-dengue initiative. Mosquito larvae ...
The Quezon City government has warned its residents that dengue remains a major health concern in the city after over 5,000 ...